The University of Cambridge is a collegiate public research university in Cambridge, England. Founded in 1209, Cambridge is the second-oldest university in the English-speaking world and the world's fourth-oldest surviving university.

It comprises 31 autonomous Colleges, which admit undergraduates and provide small-group tuition, and 150 departments, faculties and institutions. Cambridge researchers collaborate with colleagues worldwide, and the University has established larger-scale partnerships in Asia, Africa and America.

The University sits at the heart of one of the world’s largest technology clusters and has created 1,500 hi-tech companies, 14 of them valued at over US$1 billion and two at over US$10 billion. Cambridge promotes the interface between academia and business, and has a global reputation for innovation.

The Synthetic Biology Strategic Research Initiative at The University of Cambridge is a Multidisciplinary Synthetic Biology Research Centre. It was established in 2013 with the support of the Schools of Biological Sciences, Physical Sciences and Technology to bring together related activities by researchers across the University. It provides a hub for anyone interested in synthetic biology at the University of Cambridge, including researchers, commercial partners and external collaborators.